Serina Therapeutics, Inc. has announced its Annual Meeting of Stockholders, scheduled to take place on November 7, 2025. During the meeting, stockholders will vote on the election of two Class II directors, with nominees including Steve Ledger.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001708599-25-000112), on September 15, 2025, and is solely responsible for the information contained therein.